Biospectrum, Inc.
Records under this name other than the patents Biospectrum, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Showing 1 to 6 of 6 · Back to Biospectrum, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,495,071 | Antiproliferative peptides and antibodies for their detection Lapsed on the fee record Ended Feb 24, 2021 · From the USPTO record | Lapsed on the fee record | Ended Feb 24, 2021 | From the USPTO record |
| US 7,476,649 | Antiproliferative and antiviral proteins and peptides Term ended Term ended Aug 8, 2020 · From the USPTO record | Term ended | Term ended Aug 8, 2020 | From the USPTO record |
| US 6,037,446 | Gestational agents for controlling cell proliferation Term ended Term ended Jan 15, 2017 · From the USPTO record | Term ended | Term ended Jan 15, 2017 | From the USPTO record |
| US 4,723,000 | Human interferon gamma and interleukin-2 Term ended Term ended no later than Feb 2, 2008 · Low confidence | Term ended | Term ended no later than Feb 2, 2008 | Low confidence |
| US 4,732,683 | Purification method for alpha interferon Term ended Term ended no later than Mar 22, 2008 · Low confidence | Term ended | Term ended no later than Mar 22, 2008 | Low confidence |
| US 5,648,340 | Gestational agents for controlling cell proliferation Term ended Term ended no later than Jul 15, 2017 · Low confidence | Term ended | Term ended no later than Jul 15, 2017 | Low confidence |